Conclusions
insomnia
In this pilot randomized clinical trial, the culturally adapted Chinese smartphone-based DCBT-I app reduced the severity of insomnia and improved sleep quality compared with a sleep education control. These findings suggest that culturally adapted DCBT-I is suitable for the large population of patients with insomnia in China. Future multicenter clinical trials with large sample sizes are needed to validate its effectiveness in the Chinese population.